Information

International symposium:UNDERSTANDING OF NOVEL BIOLOGICAL PHENOMENA IN CANCER AND IMMUNOLOGY RESEARCH

Promotion office of Research environment for Diversity(Ree-D) provides support for the holding of online international research meetings by female researchers (applications for FY2021 have been closed), with the aim of strengthening the leadership skills of female researchers at Hokkaido University through holding research meetings and other events, as well as building a global network that will lead to future research development.
 
With this support, we are pleased to announce that an international online symposium will be held by Dr. Nako Maishi, Vascular Biology and Molecular Pathology, Dental Med, Hokkaido Univ.

Title “Understanding of Novel Biological Phenomena in Cancer and Immunology Research”
Date January 27th THU, 2022 9:00-11:00
Venue Zoom(No entry fee. Registration required.)
Registrations Please use the application form below to apply.
Application Form
Program 〈Opening remarks 〉 9:00-9:05 : Kyoko Hida

〈Session 1〉 9:05-10:00 Chair: Kyoko Hida(Vascular Biology and Molecular Pathology,Dental Med, Hokkaido Univ)
 
1. Nako Maishi(Vascular Biology and Molecular Pathology, Dental Med, Hokkaido Univ)
“The Role of tumor endothelial cells in tumor progression”
 
2. Hiroko Nagao Kitamoto(Gastroenterology, Dept of Internal Medicine, The University of Michigan Medical school)
“IL-22-mediated host glycosylation prevents C. difficile infection
via modulating the luminal metabolism of the gut microbiota”
 
〈Session 2〉 10:00-10:55 Chair: Mikako Ogawa(Bioanalysis Molecular Imaging, Pharm Sci, Hokkaido Univ)
 
3. Masumi Tsuda(Cancer Pathology, Med, Hokkaido Univ/ Institute for Chemical Reaction
Design and Discovery (WPI ICReDD ), Hokkaido
“Research development and medical application of cancer stem
cells using high functioning hydrogel”
 
4. Noriko Sato(Molecular Imaging Branch, National Cancer Institute, National Institutes of Health)
“Rapid activation of intra tumoral immune microenvironment and IFN γ mediated tumor vessel regression”
 
〈Closing remarks 〉 10:55 11:00 : Mikako Ogawa

—————————————————————————————————————-